| 23rd Jul 2026 9:25 am |
RNS |
Grant of Director Share Options |
| 21st Jul 2026 5:23 pm |
RNS |
Holding(s) in Company |
| 21st Jul 2026 5:21 pm |
RNS |
Holding(s) in Company |
| 21st Jul 2026 11:36 am |
RNS |
Holding(s) in Company |
| 17th Jul 2026 11:21 am |
RNS |
Result of AGM and Completion of Acquisition |
| 17th Jul 2026 7:00 am |
RNS |
AGM Statement |
| 24th Jun 2026 3:21 pm |
RNS |
Posting of Annual Report and Notice of AGM |
| 24th Jun 2026 7:00 am |
RNS |
Acquisition and £2.75 million Fundraise |
| 23rd Jun 2026 5:04 pm |
RNS |
Final Results |
| 9th Jun 2026 7:00 am |
RNS-R |
New article: RNA medicine enters its second act |
| 2nd Jun 2026 8:57 am |
RNS-R |
CEO Interview |
| 13th May 2026 11:12 am |
RNS-R |
CEO Interview: Thalia’s RNA Therapeutics Strategy |
| 20th Apr 2026 7:00 am |
RNS |
Change of Registered Address |
